Large Randomized Trial Finds Proton Therapy Offers No Survival Advantage in Advanced Liver Cancer
The Phase III NRG-GI003 trial was stopped early for futility after proton therapy failed to improve overall survival compared with ...
The Phase III NRG-GI003 trial was stopped early for futility after proton therapy failed to improve overall survival compared with ...
A Mayo Clinic analysis of 1,364 cancer patients links distinct gut microbiome patterns to five cancer groups, early-onset colorectal and ...
Researchers have identified the lipid sphingomyelin (30:1; O2) as a blood-based biomarker that outperforms conventional tumor markers in distinguishing intrahepatic ...
A new rat study in BMC Cancer reports that curcumin and piperine, especially in combination, prevent chemically induced hepatocellular carcinoma ...
A propensity score-matched study finds that 5-HT3 receptor antagonist anti-nausea drugs are associated with significantly improved survival in patients with ...
New research reveals that the ubiquitin-editing enzyme A20 promotes the degradation of the pro-tumor protein osteopontin in hepatocellular carcinoma, offering ...
A new probabilistic deep learning model called ResolVI corrects misassigned RNA molecules and batch effects in spatial transcriptomics data, sharpening ...
A multicenter study shows that grading the severity of microvascular invasion in resected liver tumors strongly predicts recurrence and survival ...
A comparative study of 104 liver cancer patients shows that geometric, perfusion-based, and deep learning models each excel at different ...
New preclinical research shows that the plant compound coumarin activates natural killer cells, boosts their mitochondrial energy supply, and shrinks ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine